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Abstract
Background: Relative contribution of these infections on anemia in pregnancy is not certain. While measures to protect
pregnant women against malaria have been scaling up, interventions against helminthes have received much less attention.
In this study, we determine the relative impact of helminthes and malaria on maternal anemia.
Methods: A prospective observational study was conducted in coastal Kenya among a cohort of pregnant women who
were recruited at their first antenatal care (ANC) visit and tested for malaria, hookworm, and other parasitic infections and
anemia at enrollment. All women enrolled in the study received presumptive treatment with sulfadoxine-pyrimethamine,
iron and multi-vitamins and women diagnosed with helminthic infections were treated with albendazole. Women delivering
a live, term birth, were also tested for maternal anemia, fetal anemia and presence of infection at delivery.
Principal Findings: Of the 706 women studied, at the first ANC visit, 27% had moderate/severe anemia and 71% of women
were anemic overall. The infections with highest prevalence were hookworm (24%), urogenital schistosomiasis (17%),
trichuria (10%), and malaria (9%). In adjusted and unadjusted analyses, moderate/severe anemia at first ANC visit was
associated with the higher intensities of hookworm and P. falciparum microscopy-malaria infections. At delivery, 34% of
women had moderate/severe anemia and 18% of infants’ cord hemoglobin was consistent with fetal anemia. While none of
the maternal infections were significantly associated with fetal anemia, moderate/severe maternal anemia was associated
with fetal anemia.
Conclusions: More than one quarter of women receiving standard ANC with IPTp for malaria had moderate/severe anemia
in pregnancy and high rates of parasitic infection. Thus, addressing the role of co-infections, such as hookworm, as well as
under-nutrition, and their contribution to anemia is needed.
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Introduction
Anemia affects nearly 25% of all pregnancies worldwide and
more than 40% of those in Sub-Saharan Africa [1]. Associated
with poor pregnancy outcomes including increased risk of fetal
death and preterm birth, maternal anemia also increases risk of
maternal mortality associated with obstetric hemorrhage and
severe morbidities [1–5]. Defined as hemoglobin ,11 g/dL,
anemia in pregnancy contributes to maternal morbidities and
increased risk for mortality associated with conditions such as post-
partum hemorrhage [1,6]. Maternal anemia may also lead to fetal
anemia, and, subsequently, to infant anemia as well as long-term
childhood morbidities, including impaired neurodevelopmental
outcomes [5,7–10].
Although anemia in pregnancy is multi-factorial, poor nutrition
and infection are common causes. In Sub-Saharan Africa, soil-
transmitted helminthes (STH) including hookworm, urogenital
schistosomiasis, and other parasitic infections such as malaria
contribute to the high anemia rates in women and young children
[11–18]. Helminthic infection prevalence of up to 50% has been
documented in some regions in Sub-Saharan Africa [19].
Estimates suggest that more than 25% of pregnant women are
infected with hookworm, which causes intestinal bleeding and
blood loss, and has been most commonly associated with anemia
[1,19–23]. In a study of parasitic infection in pregnancy conducted
in coastal Kenya from 2000 to 2005, about 32% of women
were infected with hookworm, 31% with urogenital schistoso-
miasis (Schistosomiasis haematobium), and almost 43% with malaria
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(Plasmodium falciparum), while more than 46% of women were co-
infected [24].
Parasitic infections, including hookworm, may be evaluated by
intensity of infection, as measured by the concentration of eggs in
the stool [25]. While most morbidity has been seen with high
intensity infections, in populations with low iron stores, even low-
intensity hookworm infection has been associated with morbidities
[25–30]. In addition to hookworm, P. falciparum malaria increases
risk for moderate and severe maternal anemia [11–16]. While
urogenital schistosomiasis causes adverse health outcomes includ-
ing anemia, its association with maternal anemia has been less
clearly established [27,28]. Finally, poor nutrition, which contrib-
utes to inadequate intake of iron, folate, and other micronutrients,
is common in the geographic areas where these parasitic infections
are prevalent, and may have an important role in the relationship
of infections and anemia [29–33].
Many studies have focused on the effects of a single infectious
agent on pregnancy outcome and maternal anemia, although a
few studies have attempted to understand the relative effects of
multiple agents with conflicting results [24,30,31]. Fetal anemia
has been documented in association with maternal anemia, with
rates of 10% to 23% reported in recent studies in Malawi [5,7] but
its association with infection is less well understood.
With preventative treatment during pregnancy with sulfadox-
ine-pyrimethamine (IPTp-SP) as recommended by the World
Health Organization (WHO) in 2004 [34], rates of malaria in
pregnancy have decreased [35–37]. Thus, other causes of
maternal anemia and poor birth outcomes have become
increasingly important. Recent trials show that presumptive
hookworm treatment reduces the infection rates in pregnancy,
although the impact on pregnancy outcomes such as maternal
anemia has varied [38–40]. Where hookworm infection is
endemic, the WHO recommends provision of antihelminthic
treatment (e.g., albendazole or other treatments safe during
pregnancy) in the second trimester [41]. Furthermore, safe,
effective treatment is available to treat urogenital schistosomiasis
during pregnancy and endorsed by the WHO [42,43]. However,
for various reasons, the WHO recommendations for hookworm
and urogenital schistosomiasis treatment during pregnancy have
not been widely implemented [40,44]. In this study, we sought to
ascertain the contributions of parasitic infection to maternal and
fetal anemia among a cohort of pregnant women in coastal Kenya.
Methods
We conducted a secondary analyses of a large, prospective
cohort study on fetal immunity conducted in coastal Kenya from
2006–2009. During that period trained study nurses recruited
pregnant women between 20 and 32 weeks gestation who were
residents of the area for the study at their first antenatal care
(ANC) visit at Mswambweni District Hospital, Mswambweni, in
Coast Province Kenya. Women who delivered live, term births at
the study hospital had follow-up exam completed. At the first ANC
visit, blood, stool and urine samples were collected, in addition to
maternal anthropometrics, and basic demographic information.
All women diagnosed with helminthic infections were treated with
albendazole. Women were not treated for urogenital schistosomi-
asis during pregnancy, but treatment (e.g., praziquantel) was
delayed until after delivery, per standard care in Kenya during the
study period. All women enrolled in the study received IPTp-SP,
one month of iron tables (60 mg/day) and folate (400 ug/day),
and multi-vitamins for the duration of their pregnancy per Kenyan
national guidelines.
Ethics Statement
All women provided written informed consent prior to study
enrollment. Institutional review board approval was received by
Case Western Reserve University, Kenya Medical Research
Institute, and the University of North Carolina at Chapel Hill.
Measures
Blood was drawn at ANC visits to make both thick and thin
blood smears at antenatal care and at delivery for maternal
peripheral, cord and placental samples. The remaining blood was
processed and stored at the laboratory, under temperature
controlled conditions, for subsequent PCR analyses. P. falciparum
malaria was determined by microscopy using the standard Giemsa
stain (thick and thin slices) on site and post-study by PCR/Ligase
Detection Reaction Fluorescent Microsphere Assay, as previously
described [45]. PCR is considered to have high sensitivity to detect
malaria parasitemia; however, microscopy, which is more
commonly used in clinical settings, is generally considered reliable
to detect malaria present in higher concentrations [46]. For this
study, as exposures of interest, microscopy was defined as a proxy
for high intensity malaria infection and PCR-positive malaria as
any malaria infection.
Maternal stool and urine samples were collected at the first
ANC visit and at delivery. Study participants brought a morning
stool sample to the respective visit and these stool specimens were
brought to the laboratory immediately following the collection by
the health worker. Stool samples were tested for hookworm
infection and other STH (Ascaris lumbricoides, Trichuris trichuria,
Strongyloides stercoralis). Approximately one gram of fresh stool
specimen was processed and examined by Richtie’s concentration
method [47]. STH infections were determined by the presence of
ova or larva in the stool sample. Burden was also determined by
count of parasites/gram. Urine samples were collected and
processed by the laboratory immediately following collection.
Urine was evaluated for presence of urogenital schistosomiasis (S.
haematobium) and results expressed as number of eggs/mL.
Schistosomiasis was also categorized as light (0–,50 eggs/mL)
or moderate ($50 eggs/mL), according to WHO criteria [42].
Hemoglobin (Hb) levels were measured at the first ANC visit
and at delivery by Coulter counter (Beckman Coulter Inc.).
Women were classified as anemic (Hb,11 g/dL) and then
categorized as being moderately to severely anemic (Hb,9 g/
dL), as the primary outcome, and being mildly to non-anemic
Author Summary
International guidelines recommend routine prevention
and treatments which are safe and effective during
pregnancy to reduce hookworm, malaria and other
infections among pregnant women living in geographic
areas where these infections are prevalent. Despite their
effectiveness, programs to address common infections
such as hookworm, schistosomiasis and malaria during
pregnancy have not been widely adopted. Hookworm,
malaria and other infections have been associated with
anemia in children, but the studies on the impact of these
infections on anemia in pregnancy have not been as clear.
This study was undertaken to evaluate the prevalence of
parasitic infections among women attending antenatal
care which provided the nationally recommended malaria
preventive treatment program in coastal Kenya. At the first
ANC visit, more than 70% of women were anemic, nearly
one-fourth had hookworm and about 10% had malaria.
Women with high levels of hookworm or malaria infections
were at risk of anemia.
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(Hb$9 g/dL) according to the WHO classification of anemia [1].
Cord blood hemoglobin levels were also determined and cord
(fetal) hemoglobin defined by hemoglobin ,12.5 g/dL, as pre-
viously defined [7].
Maternal height and weight were taken at the first ANC visit
(generally in the second trimester) and body mass index (BMI)
calculated as kg/m2. Since pre-pregnancy BMI was unavailable, to
assess BMI, low BMI was defined as the lowest 10th percentile for
the gestational age at measurement. The overall BMI ranged from
19.5 to 31.4 kg/m2 and the 10th percentile cut-off for GA at
measurement ranged from 19.8 to 20.7 kg/m2. Trained study
nurses interviewed the women at antenatal care visit to obtain key
socio-demographic and basic medical history.
Analyses
The study was a secondary analysis of data collected as part of a
larger study to evaluate the association of in utero malaria infection
on neurodevelopmental outcomes (NCT00314899). Analyses were
performed in SAS version 9.3 (SAS Institute, Cary, NC, USA).
Descriptive analyses were performed. Parity, gestational age,
maternal age, maternal education, and socio-economic status (as
measured by monthly household expenditures) were evaluated as
potential confounders, based on previous research [14,17,19–23].
The risk ratios for moderate/severe anemia associated with each
of infections evaluated are presented with and without the
potential confounders, using a log-binomial regression model. A
backward elimination strategy was employed to estimate the
adjusted RR of moderate/severe maternal anemia associated with
infections and maternal BMI, accounting for the potential
confounders. An a priori cut-off (p,0.15) was defined for variable
to be considered significant and retained in the final regression
model. Analyses were restricted to those with complete case
information.
Results
Of the 813 women screened at ANC, 706 (88%) consented
women had blood and urine samples available for anemia,
malaria, and schistosomiasis evaluation, respectively. Of these
participants, 544 (71%) provided stool samples at antenatal care






(Hg$9) RR (95% CI){
N (%) N (%)
Number enrolled 190 (27) 516 (73) –
Maternal age
20–44 154 (81) 420 (81) Referent
,20 36 (19) 96 (19) 1.02 (0.75, 1.39)
Marital status
Married/partner 163 (86) 453 (88) Referent
Widow/divorced/single 26 (14) 58 (12) 1.05 (0.95, 1.16)
Formal education
No education 43 (23) 105 (21) Referent
Primary education 124 (65) 344 (67) 0.99 (0.68, 1.45)
Secondary/higher education 23 (12) 63 (12) 0.98 (0.46, 2.10)
Gravidity
Multigravida 145 (77) 385 (75) Referent
Primigravida 42 (23) 128 (25) 0.97 (0.90, 1.04)
Body Mass Index (BMI), m/kg2`
Low BMI 154 (84) 444 (88) Referent
Normal BMI 30 (16) 62 (12) 1.30 (0.94, 1.81)
Bednet last 3 mos
Used bednet 134 (71) 386 (75) Referent
Not used bednet 53 (28) 127 (25) 1.14 (0.87, 1.50)
Malaria treated last 3 mos
Treatment provided 18 (9) 53 (10) Referent
No treatment 171 (91) 460 (90) 1.07 (0.70, 1.63)
Folic acid/iron-last 3 mos
Folic acid/iron 11 (6) 28 (5) Referent
No folic acid/iron 178 (94) 487 (95) 0.99 (0.96, 1.03)
*Numbers less than total enrolled reflect missing data.
{Unadjusted Risk ratio (RR) and 95% confidence intervals (CI).
`Adjusted for gestational age.
doi:10.1371/journal.pntd.0002724.t001
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for measurement of STHs and 394 had outcomes at delivery
available.
At enrollment at first ANC, the mean gestational age was 24.5
weeks (SD 3.8 weeks). 516 (71%) were anemic (Hb,11 g/dL) and
190 (27%) had moderate to severe anemia (Hb,9 g/dL). For
subsequent analyses, moderate/severe anemia was evaluated as
the primary outcome of interest. About 19% of the women were
,20 years of age, nearly 86% were married, 21% had no formal
education, and about 23% were primagravidas (Table 1). In
unadjusted analyses, these factors were not associated with
increased risk of anemia. Insecticide-treated bednet use, malaria
treatment, and iron/folic acid received 3 months prior to the ANC
visit were also not associated with moderate/severe anemia risk.
Few women (,2%) received anti-helminth treatment prior to first
ANC (data not shown).
The association of demographic characteristics and the preva-
lence at first ANC of hookworm infection, PCR-positive malaria
(P. falciparum), and urogenital schistosomiasis (S. haematobium) are
summarized in Table 2. Risks of P. falciparum PCR-positive (RR
2.29, 95% CI 1.38, 3.79), hookworm (RR 1.42, 95% CI 1.02,
1.98), and urogenital schistosomiasis infection (RR 2.25, 95% CI
1.66, 3.07) were higher among those ,20 years compared to
women$20 years. Risks for infection did not differ significantly by
maternal education levels. Primigravidity was associated with
increased risk of P. falciparum PCR-malaria (RR 1.52, 95% CI
1.11, 2.56) and urogenital schistosomiasis (RR 1.51, 95% CI 1.07,
1.78), but not hookworm infection. About one-fourth (25.7%) of
the women reported no use of insecticide-treated bednets (ITNs)
prior to enrollment, which was associated with increased risk of
malaria infection (RR 2.00, 95% CI 1.23, 3.27).
Hookworm (23.7%), P. falciparum PCR-malaria (10.8%),
S. haematobium (17.1%), and T. trichuria (10.1%) were the most
common infections at the first ANC visit. Of women positive for
one of these infections, approximately 10% were co-infected, 4%
with urogenital schistosomiasis and hookworm, and 2% with
either malaria and hookworm or malaria and schistosomiasis, and
the remaining with another combination (data not shown).
Hookworm intensity ranged from 1 to 1035 eggs/g; thus all were
considered ‘light’ according to the WHO criteria (light defined as
,1999 eggs/g). To further evaluate whether relative intensity of
infection was associated with outcomes, we also classified the
highest intensity of infection ($100 eggs/g) among the cohort as
‘moderate’ infection.
We next examined the risk for moderate/severe maternal
anemia at ANC associated with these infections, in unadjusted and
adjusted analyses (Table 3). In analyses adjusted for gestational
age, primagravid status, and low BMI, moderate/severe anemia
was associated with moderate hookworm infection (aRR 2.53,
95% CI 1.62, 3.92), P. falciparum PCR-positive and microscopy
positive (aRR 1.45, 95% CI 1.01, 2.08 and aRR 1.98, 95% CI
1.17, 3.35, respectively). S. haematobium and T. trichuria, although
common, were not significantly associated with moderate/severe
anemia and few had moderate burden of infection. S. stercoralis and
A. lumbricodes were observed in about 1% of women, using a single
sample, which may be an under-representation since single-sample
fecal assays have low sensitivity, especially for detecting S. stercoralis
Table 2.Maternal characteristics and association with malaria, hookworm and urogenital schistosomiasis infection in pregnancy at
first ANC visit, among a cohort of pregnant women, coastal Kenya, 2006–2009.
Total P. falciparum{ Hookworm* S. haematobium
N (%) n (%) RR (95% CI) n (%) RR (95% CI) n (%) RR (95% CI)
Number 706 59 129 119
Maternal Age
20–44 574 (81.3) 39 (7.0) Referent 96 (22.1) Referent 80 (14.1) Referent
,20 132 (18.7) 20 (16.0) 2.29 (1.38, 3.79) 33 (31.4) 1.42 (1.02, 1.98) 39 (30.5) 2.25 (1.66, 3.07)
Formal education
Secondary/higher level 86 (12.2) 6 (7.0) Referent 9 (15.3) Referent 12 (14.6) Referent
Primary education 468 (66.7) 41 (9.1) 1.30 (0.57, 2.97) 86 (23.8) 1.56 (0.83, 2.93) 80 (17.4) 1.18 (0.68, 2.08)
No education 148 (21.1) 12 (8.5) 1.69 (0.32, 8.80) 34 (29.1) 2.43 (0.69, 8.58) 27 (18.2) 1.41 (0.46, 4.32)
Marital status
Married/partner 616 (88.0) 48 (8.1) Referent 115 (24.4) Referent 100 (16.5) Referent
Widow/divorced/single 84 (12.0) 10 (12.1) 1.41 (0.83, 2.40) 12 (18.7) 0.86 (0.54, 1.36) 18 (21.7) 1.18 (0.77, 1.83)
Gravidity
Multigravida 529 (75.7) 39 (7.6) Referent 95 (23.6) Referent 81 (15.9) Referent
Primigravida 170 (24.3) 19 (11.6) 1.52 (1.11, 2.56) 33 (24.6) 1.04 (0.76, 1.47) 38 (19.4) 1.51 (1.07, 1.78)
Maternal BMI
Normal BMI 598 (86.7) 51 (8.5) Referent 94 (24.8) Referent 79 (15.9) Referent
Low BMI 92 (13.3) 12 (8.7) 0.83 (0.35, 2.01) 16 (21.0) 1.08 (0.66, 1.78) 19 (19.4) 1.04 (0.60, 1.78)
Bednet use last 3 mos
Yes 520 (74.3) 24 (13.9) Referent 94 (23.6) Referent 84 (16.2) Referent
No 180 (25.7) 35 (6.9) 2.00 (1.23, 3.27) 33 (23.9) 1.01 (0.72, 1.43) 34 (19.9) 1.23 (0.86, 1.76)
*Analyses restricted to women with stool sample available at antenatal care visit (n = 544).
{PCR-diagnosed malaria.
doi:10.1371/journal.pntd.0002724.t002
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[48]. These infections were not significantly associated with
moderate/severe anemia at ANC, in adjusted or unadjusted
analyses. Among all infections, only moderate burden hookworm
and malaria were associated with moderate/severe anemia.
For those women who delivered live, term births at the study
hospital, we evaluated the association between infection at the first
ANC visit with maternal and fetal anemia at delivery, as well as the
association of infections detected at delivery for those women and
their fetuses who had stool (n = 210), or urine and blood samples
(n = 394) available at delivery. Women whose births were included
were comparable whose births were excluded (exclusion criteria
were delivery outside the study hospital, voluntary discontinuance of
study participation, lost to follow up, premature delivery, or non-
collection of samples), on socio-demographics, maternal character-
istics and infection at ANC (malaria, hookworm) (data not shown).
At delivery, 34.2% of the women had moderate/severe anemia
and 18.4% of the neonates had fetal anemia (cord Hb,12.5 g/
dL). Moderate hookworm burden at the first ANC visit was
associated with moderate/severe maternal anemia at delivery
(aRR 2.30, 95% CI 1.42, 3.71), but other infections at first ANC
visit were not significantly associated with risk of moderate/severe
maternal anemia at delivery (Table 4). Fetal anemia was not
significantly associated with any of the infections, in adjusted or
unadjusted analyses. Of women tested for presence of hookworm,
P. falciparum malaria (PCR and microscopy) and schistosomiasis at
delivery, none of these infections were significantly associated
with maternal or fetal anemia at delivery; however, there were
insufficient numbers of high-burden hookworm at delivery to test
for this association. Furthermore, hookworm infection at ANC was
associated with risk of hookworm infection at delivery and
P. falciparum malaria infection was associated with risk of malaria
infection at delivery (p,0.0001 for both).
In exploratory analyses, we also examined the association of the
anemia at ANC with maternal and fetal anemia at delivery among
210 women and their newborns with both measures available.
Women with moderate/severe anemia at first ANC visit had
increased risk of maternal anemia at delivery (unadjusted RR
3.84, 95% CI 2.94, 4.98). Fetal anemia was also associated with
moderate/severe maternal anemia at first ANC visit and
moderate/severe maternal anemia at delivery (RR 1.58, 95% CI
1.02, 2.45, p = 0.05; RR 2.75, 95% CI 1.78, 4.24, p,0.001,
respectively) (data not shown).
Table 3. Prevalence of parasitic infections in pregnancy and association of moderate/severe maternal anemia (Hg,9) at first ANC
visit, among a cohort of pregnant women in coastal Kenya, 2006–2009.
Infection Moderate/severe anemia p-value Moderate/severe anemia p-value
N* (%) Unadjusted RR (95% CI) aRR{ (95% CI)
Hookworm
Absent 415 (76.3) Referent Referent
Present 129 (23.7) 1.15 (0.86–1.55) 0.3 1.17 (0.88, 1.56) 0.3
0–,100 eggs/g 534 (98.2) Referent Referent
.100 eggs/g 10 (1.8) 2.45 (1.60, 3.77) ,0.0001 2.53 (1.62, 3.92) ,0.0001
P. falciparum
PCR-negative 631 (91.1) Referent Referent
PCR-positive 59 (8.6) 1.38 (0.96, 2.00) 0.08 1.45 (1.01, 2.08) 0.05
MS-negative 516 (95.8) Referent Referent
MS-positive 24 (4.6) 2.12 (1.26, 3.57) 0.004 1.98 (1.17, 3.35) 0.01
S. haematobium
Absent 577 (82.9) Referent Referent
Present 119 (17.1) 1.00 (0.92, 1.09) 1.0 1.00 (0.92, 1.10) 0.9
0–,50 eggs/mL 670 (96.3) Referent Referent
$50 eggs/mL 26 (3.7) 1.15 (0.64, 2.08) 0.6 1.23 (0.68, 2.22) 0.5
T. trichura
Absent 489 (89.9) Referent Referent
Present 55 (10.1) 1.06 (0.70–1.62) 0.8 1.10 (0.73, 1.67) 0.5
0–,100 eggs/g 542 (99.6) – –
$100 eggs/g 2 (0.4)
S. stercoralis
Absent 537 (99.1) Referent Referent
Present` 5 (0.9) 0.68 (0.12–3.94) 0.7 0.43 (0.07, 2.70) 0.4
A. lumbricodes
Absent 535 (98.5) Referent Referent
Present` 8 (1.5) 0.42 (0.07–2.66) 0.4 0.67 (0.12, 3.86) 0.7
*Numbers differ due to missing values;
{Adjusted for primagravid status, gestational age at ANC, and low maternal BMI;
`None of the participants had $50 eggs/mL; MS =Microscopy diagnosed malaria.
doi:10.1371/journal.pntd.0002724.t003
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Finally, a multivariate regression model was developed to assess
the infections identified as risk factors associated with moderate/
severe maternal anemia at ANC. We found that moderate
hookworm (aRR 2.37, 95% CI 1.44, 3.91, p = 0.0007) and
P. falciparum microscopy-positive malaria infection (and aRR 2.06,
95% CI 1.24, 3.44, p = 0.005, respectively) remained significantly
Table 4. Association of infections and maternal and fetal anemia at delivery, coastal Kenya, 2006–2009.
Maternal moderate/severe anemia (Hb,9 g/dl) at
delivery Fetal anemia (Hb,12.5 g/dl)
N{ (%) RR (95% CI) p-value aRR (95% CI)* p-value RR (95% CI) p-value aRR (95% CI)* p-value
Infection at first ANC
Hookworm
Negative 218 (78) Referent Referent Referent Referent
Positive 61 (22) 0.76 (0.52, 1.12) 0.2 0.81 (0.55, 1.20) 0.3 1.10 (0.64, 1.90) 0.7 1.13 (0.65, 1.95) 0.6
0–,100 eggs/mL 274 (98) Referent Referent Referent 1.0
$100 eggs/mL 5 (2) 2.43 (1.52, 3.90) 0.0002 2.30 (1.42, 3.71) 0.0006 1.91 (0.58, 6.08) 0.3 1.84 (0.58, 5.84) 0.3
P. falciparum
PCR-negative 310 (89) Referent Referent Referent Referent
PCR-positive 37 (11) 1.12 (0.45, 2.78) 0.8 1.02 (0.41, 2.54) 1.0 1.58 (0.44, 5.62) 0.5 1.45 (0.43, 4.91) 0.5
MS-negative 330 (95) Referent Referent Referent Referent
MS-positive 17 (5) 1.16 (0.47, 2.89) 0.7 1.08 (0.43, 2.75) 0.9 1.22 (0.44, 3.40) 0.7 1.42 (0.50, 3.97) 0.3
S. haematobium`
Negative 310 (83) Referent Referent Referent Referent
Positive 62 (17) 1.05 (0.92, 1.19) 0.4 1.05 (0.93, 1.20) 0.4 0.75 (0.21, 2.76) 0.7 0.61 (0.17, 2.21) 0.5
Infection at delivery
Hookworm`
Negative 177 (84) Referent Referent Referent Referent
Positive 33 (16) 1.07 (0.63, 1.82) 0.8 1.08 (0.64, 1.84) 0.8 1.14 (0.52, 2.50) 0.7 1.10 (0.51, 2.41) 0.5
P. falciparum
PCR-negative 353 (89) Referent Referent Referent Referent
PCR-positive 41 (11) 1.43 (0.94, 2.20) 0.09 1.48 (0.97, 2.27) 0.07 1.58 (0.82, 3.01) 0.2 1.60 (0.84, 3.06) 0.2
MS-negative 384 (97) Referent Referent Referent Referent
MS-positive 10 (3) 1.35 (0.69, 2.60) 0.4 1.42 (0.74, 2.74) 0.3 1.66 (0.63, 4.36) 0.3 1.69 (0.64, 4.45) 0.3
S. haematobium`
Negative 244 (84) Referent Referent Referent Referent
Positive 49 (16) 0.98 (0.63, 1.53) 0.9 0.97 (0.62, 1.53) 0.9 0.80 (0.38, 1.66) 0.5 0.74 (0.36, 1.57) 0.4
*Adjusted for primagravid status and low BMI.
{Different denominators reflect missing samples;
`insufficient n to assess moderate burden.
MS=Microscopy diagnosed malaria.
doi:10.1371/journal.pntd.0002724.t004
Table 5. Factors associated with moderate/severe maternal anemia at first ANC among a cohort of pregnant women, coastal
Kenya 2006–2009.
Maternal moderate/severe (Hb,9 g/dL) anemia at ANC
aRR (95% CI)* p-value
Hookworm ($100 eggs/g) 2.37 (1.44, 3.91) 0.0007
P. falciparum (MS-positive) 2.06 (1.24, 3.44) 0.005
Low BMI 1.25 (0.86, 1.81) 0.2
Primigravida 0.78 (0.54, 1.11) 0.2
*Regression model adjusted for all variables listed and gestational age.
ANC=Antenatal care; MS =microscopy.
doi:10.1371/journal.pntd.0002724.t005
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associated with moderate/severe maternal anemia at ANC,
when adjusting for primigravid status and low maternal BMI
(Table 5).
Discussion
Few studies have examined the burden of helminthic infection
and under-nutrition in pregnancy on maternal and fetal anemia in
malaria-endemic regions. This is now especially important in
geographic areas with a declining incidence of malaria found with
widespread use of insecticide-treated bednets and IPTp-SP [49–
51]. In this study of pregnant women at ANC, the prevalence of P.
falciparum PCR-malaria had fallen to 9% from previous rates of
40% at delivery reported in a similar region in Kenya, prior to
widespread IPTp-SP and ITN’s [24]. Despite this decline in the
malaria rate, 71% of the pregnant women studied were anemic,
and overall more than 25% had moderate/severe anemia.
Infection with hookworm (24%), and schistosomiasis (17%), which
had less significant reductions since the previous study period [24],
were also common, although most hookworm infections were
light. Both P. falciparum malaria as diagnosed by microscopy and
moderate hookworm infections at ANC were associated with
moderate/severe anemia at the ANC visit, while urogenital
schistosomiasis and trichurisis and light infections were not. No
association between PCR-detected malaria infections and anemia
was found, probably because malaria detected by PCR included
many low-level parasitemias. Thus, our findings are consistent
with previous studies showing an association with anemia among
populations with higher rather than low-intensity parasitic
infection [11]. Compared to the first ANC visit, the prevalence
and burden of both infections at delivery were lower and neither
type of infection was significantly associated with anemia at
delivery. The decrease infection rates detected at delivery may be
related to restricting analyses to women with term, live births as
well as the consequence of the enhanced treatment and care given
to this study cohort.
Socio-demographic factors assessed including age, gravidity,
education, socio-economic and marital status, and low BMI were
not significantly associated with moderate/severe maternal anemia
in this cohort. However, the study was conducted among a
relatively homogenous community, and thus these disparities may
not have been large enough to be detectable. One limitation was
that pre-pregnancy BMI and additional measures of under-
nutrition were not available for this cohort and thus a more
sophisticated assessment of the relationship of nutritional intake
and anemia was not possible. Our findings are also consistent with
research suggesting that in the context of low socio-demographic
status, even light infections such as hookworm and malaria may be
associated with anemia [27,52]; however, further research is
needed to address these relationships.
In low-resource areas where hookworm, malaria, and other
parasitic infections, in addition to poor nutritional intake, are
common, maternal anemia is prevalent and adversely affects the
health of both women and their children. In this study, maternal
anemia was associated with increased risk of fetal anemia. While
we found no significant association of fetal anemia with maternal
infection, these results should be interpreted with caution given the
restriction to live, term births and the relatively small sample size,
reducing our ability to detect differences. While fetal anemia has
been less well studied, emerging research suggests that it may also
be common in areas with high-burden of infection [5–7,53]. Since
fetal and childhood anemia associated with maternal anemia
potentially may lead to long-term impaired neurologic function, 8–
10, a better understanding of etiology and effects of fetal anemia is
important.
Effective, safe treatments are available to prevent and treat
hookworm and malaria, both of which were associated with
maternal anemia in this study. While numerous studies have
evaluated preventative treatment for malaria in pregnancy,
fewer have assessed antihelminthic treatment in the context of
malaria treatment. Of those that have assessed hookworm, the
results suggested that benefit may be most pronounced among
women with higher burden of hookworm infection [22–24,54–
56]. Additionally, few studies have evaluated the roles of
multiple infections and under-nutrition in pregnancy and
interventions. In a study assessing the role of malaria,
hookworm, and nutrition in Uganda, malaria was significantly
associated with maternal anemia while hookworm and nutrition
were not. The authors speculated that this was in part due to the
relatively good nutritional indicators and coverage of helminthic
treatment in the region, while malaria prevention strategies were
limited [54].
In contrast to the Uganda study, in our study, while all women
in this study received antenatal care including IPTp-SP for
malaria, treatment for hookworm as indicated, and iron/folic acid,
most were not enrolled until after 20 weeks gestation. Thus, even
with relatively good antenatal care, treatment was not initiated
until the second trimester at which time anemia was prevalent in
this cohort. Furthermore, unlike the region where this study was
conducted and despite the international recommendations, uptake
of treatment for hookworm, malaria, and schistosomiasis in ANC
is still low in many parts of Africa [40,56]. In part, this may
relate to perceptions that treatment has not been associated with
improved pregnancy outcomes [38], or may be harmful [40].
Given the high prevalence of anemia seen in our study and
elsewhere implementation of known effective interventions prior to
or early in pregnancy to reduce anemia and ultimately reduce
maternal and newborn mortality is needed.
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